The state of lipid peroxidation and antioxidants following thrombolytic therapy with rt-PA and streptokinase in acute myocardial infarction

Japanese Heart Journal

Volumn 40, Issue 3, 1999, Pages 267-273

  Özmen, Dilek ^a   Boydak, Bahar ^a   Mutaf, Isil ^a   Zoghi, Mehdi ^a   Kumanlioǧlu, Kamil ^a   Güner, Inci ^a   Bayindir, Oya ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antioxidant vitamins; Free oxygen radicals; Reperfusion; Thrombolysis

Indexed keywords

ALPHA TOCOPHEROL; ALTEPLASE; ANTIOXIDANT; ASCORBIC ACID; FREE RADICAL; LIPID; LIPID PEROXIDE; STREPTOKINASE;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FIBRINOLYTIC THERAPY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

ANTIOXIDANTS; ASCORBIC ACID; FIBRINOLYTIC AGENTS; FREE RADICALS; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; RECOMBINANT PROTEINS; STREPTOKINASE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; VENTRICULAR FUNCTION, LEFT; VITAMIN E;

EID: 0033031519     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.40.267     Document Type: Article

References (16)

1. Young IS, Purvis JA, Lightbody JH, Adgey AAJ, Trimble ER. Lipid peroxidation and oxidant status following thrombolytic therapy for acute myocardial infarction. Eur Heart J 1993; 14: 1027-33.
2. Giardina B, Penco M, Lazzarino G, et al. Effectiveness of thrombolysis is associated with a time-dependent increase of malondialdehyde in peripheral blood of patients with acute myocardial infarction. Am J Cardiol 1993; 71: 788-93.
3. De Scheerder IK, van de Kraay AMM, et al. Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: potential mechanism for free radical generation. Am J Cardiol 1991; 68: 392-5.
4. Davies SW, Ranjadayalan K, Wickens DG, Dormandy TL, Timmis AD. Free radical activity at the time of successful thrombolysis: relation to left ventricular function. Br Heart J 1990; 64: 83.
5. Davies SW, Ranjadalayan K, Wicken DG, Dormandy TL, Timmis AD. Lipid peroxidation associated with successful thrombolysis. Lancet 1990; 335: 741-43.
6. Roberts MJD, Young IS, Trouton TG, et al. Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet 1990; 336: 143-5.
7. Levy L, Bartha P, Ben-Amoyz A, et al. Plasma antioxidants and lipid peroxidation in acute myocardial infarction and thrombolysis. J Am Coll Nutr 1998; 17: 337-41.
8. Miller NJ, Johnston JD, Collis CS, Rice-Evans C. Serum total antioxidant activity after myocardial infarction. Ann Clin Biochem 1997; 34: 85-90.
9. Gerritsen WB, Aarts LP, Morshuis WJ, Haas FJ. Indices of oxidative stress in urine of patients undergoing coronary artery bypass grafting. Eur J Clin Chem Clin Biochem 1997; 35: 737-42.
10. Yagi K. Assay for blood plasma or serum. Meth Enzymol 1984;105:328-31.
11. Martinek RG. Method for determination of vitamin E (total tocopherols) in serum. Clin Chem 1964; 10: 1078-86.
12. Mc Cormick DB, Green HL. Vitamins. In: Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry. Philadelphia: W.B. Saunders Company. Second Edition 1994; 1313.
13. Pucheu S, Coudray C, Vanzetto G, Favier A, Machecourt J, de Leritis J. Assesment of radical activity during the acute phase of myocardial infarction following fibrinolysis: utility of assaying plasma malondialdehyde. Free Radic Biol Med 1995; 19: 873-81.
14. Davies SW, Radjadayalan K, Wickens DG, Dormandy TL, Umachandran V, Timmis AD. Free radical activity and left ventricular function after thrombolysis for acute infarction Br Heart J 1993; 69: 114-20.
15. Mickelson JK, Simpson PJ, Jackson CV, Lucchesi BR. Protection of myocardial function and coronary vasculature by streptokinase. J Cardiovasc Pharmacol 1988; 12: 185-95.
16. Stringer KA, Lindenfeld J, Repine AJ, Cohen Z, Repine JE. Tissue plasminogen activator (tPA) inhibits human neutrophil superoxide anion production in vitro. Inflammation 1997; 21: 27-34.